Author

B. Katzman

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

A-167 Clinical Laboratory Implementation and Analytical Validation of the ELF™ Score for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Risk Stratification

The Enhanced Liver Fibrosis test (ELF™; Siemens Healthineers) is an FDA-authorized serum biomarker test for assessing metabolic dysfunction-associated steatotic liver disease (MASLD). The ELF score is calculated from hyaluronic acid (HA), amino-terminal pro-peptide of type III collagen (PIIINP), and tissue inhibi...

C. Rosemark, D. Block, B. Katzman et al. · Clinical Chemistry · 0 citations

Review Oct 2026

A-282 Analysis of Recheck and Revision Rates Across the Life Cycle of High Volume Chemistry Analyzers: Informing Lab Stewardship and Asset Management

Monitoring patient retesting and result corrections, or revision rates, following quality control (QC) failures in a high-volume clinical chemistry laboratory helps inform QC practices. Our laboratory uses rule-based statistical QC (via mean and standard deviation) to detect deviations from stable operation. Pati...

Trista Peterson, L. Leonard, L. Rossini et al. · Clinical Chemistry · 0 citations

Oct 2026

A-249 Evaluation of three cartridge-based analyzers for viscoelastic testing

Viscoelastic Testing (VET) can provide information about the status of coagulation factors, platelet count, platelet function, and fibrinolysis in fresh whole blood and is used in various critical care settings. Our current VET method, Haemonetics TEG 5000 (5000) (Boston, MA) is being discontinued in the next few...

A. Wockenfus, B. Kelley, B. Katzman et al. · Clinical Chemistry · 0 citations